These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

132 related items for PubMed ID: 7918070

  • 1. Poor response to intensive chemotherapy in de novo acute myeloid leukaemia with trilineage myelodysplasia. Japan Adult Leukaemia Study Group (JALSG).
    Kuriyama K, Tomonaga M, Matsuo T, Kobayashi T, Miwa H, Shirakawa S, Tanimoto M, Adachi K, Emi N, Hiraoka A.
    Br J Haematol; 1994 Apr; 86(4):767-73. PubMed ID: 7918070
    [Abstract] [Full Text] [Related]

  • 2. Significance of trilineage myelodysplasia in de novo acute myeloid leukaemia during remission rather than at diagnosis.
    Tamura S, Takemoto Y, Wada H, Itoh T, Mori A, Saheki K, Okada M, Takatsuka H, Fujimori Y, Okamoto T, Kakishita E.
    Br J Haematol; 1998 Jun; 101(4):743-8. PubMed ID: 9674749
    [Abstract] [Full Text] [Related]

  • 3. [Diagnosis and treatment strategy for de novo AML with trilineage myelodysplasia].
    Kuriyama K.
    Rinsho Ketsueki; 1994 Mar; 35(3):267-71. PubMed ID: 8158847
    [Abstract] [Full Text] [Related]

  • 4. [Clinical characteristics and poor outcomes in patients with de novo AML with trilineage myelodysplasia].
    Arimura K, Kuriyama K, Miyazaki Y, Nagai K, Fukushima T, Yoshida S, Moriuchi Y, Momita S, Tomonaga M.
    Rinsho Ketsueki; 1995 Feb; 36(2):98-105. PubMed ID: 7715091
    [Abstract] [Full Text] [Related]

  • 5. De-novo acute myeloid leukemia with trilineage myelodysplasia (AML/TMDS) and myelodysplastic remission marrow (AML/MRM).
    Tamura S, Kanamaru A.
    Leuk Lymphoma; 1995 Jan; 16(3-4):263-70. PubMed ID: 7719234
    [Abstract] [Full Text] [Related]

  • 6. Morphological comparison of dysplastic changes between de novo acute myeloid leukemia (AML) with trilineage myelodysplasia and AML developed from de novo myelodysplastic syndromes.
    Kuriyama K, Miyazaki Y, Arimura K, Nagai K, Nakamura H, Matsuo T, Tomonaga M.
    Leuk Res; 1995 Feb; 19(2):121-5. PubMed ID: 7869740
    [Abstract] [Full Text] [Related]

  • 7. Clinical and laboratory features of de novo acute myeloid leukaemia with trilineage myelodysplasia.
    Brito-Babapulle F, Catovsky D, Galton DA.
    Br J Haematol; 1987 Aug; 66(4):445-50. PubMed ID: 3478074
    [Abstract] [Full Text] [Related]

  • 8. Clonal evolutions during long-term cultures of bone marrow from de novo acute myeloid leukaemia with trilineage myelodysplasia and with myelodysplastic remission marrow.
    Tamura S, Kanamaru A, Takemoto Y, Kakishita E, Nagai K.
    Br J Haematol; 1993 Jun; 84(2):219-26. PubMed ID: 8398821
    [Abstract] [Full Text] [Related]

  • 9. The rate of disease progression predicts the quality of remissions following intensive chemotherapy for myelodysplastic syndromes.
    Hirst WJ, Mufti GJ.
    Leuk Res; 1994 Nov; 18(11):797-804. PubMed ID: 7967705
    [Abstract] [Full Text] [Related]

  • 10. Allogeneic bone marrow transplantation improves the outcome of de novo AML with trilineage dysplasia (AML-TLD).
    Taguchi J, Miyazaki Y, Yoshida S, Fukushima T, Moriuchi Y, Jinnai I, Matsuo T, Kuriyama K, Tomonaga M.
    Leukemia; 2000 Nov; 14(11):1861-6. PubMed ID: 11069020
    [Abstract] [Full Text] [Related]

  • 11. Cytogenetic analysis of de novo acute myeloid leukemia with trilineage myelodysplasia in comparison with myelodysplastic syndrome evolving to acute myeloid leukemia.
    Tamura S, Takemoto Y, Hashimoto-Tamaoki T, Mimura K, Sugahara Y, Senoh J, Furuyama JI, Kakishita E.
    Int J Oncol; 1998 Jun; 12(6):1259-62. PubMed ID: 9592183
    [Abstract] [Full Text] [Related]

  • 12. The significance of trilineage myelodysplasia in de novo acute myeloblastic leukemia: clinical and laboratory features.
    Lima CS, Vassalo J, Lorand-Metze I, Bechelli AP, Souza CA.
    Haematologia (Budap); 1997 Jun; 28(2):85-95. PubMed ID: 9283908
    [Abstract] [Full Text] [Related]

  • 13. Myelodysplastic relapse of de novo acute myeloid leukaemia with trilineage myelodysplasia: a previously unrecognized correlation.
    Brito-Babapulle F, Catovsky D, Galton DA.
    Br J Haematol; 1988 Apr; 68(4):411-5. PubMed ID: 3163932
    [Abstract] [Full Text] [Related]

  • 14. [Five cases of de novo acute myeloid leukemia with trilineage myelodysplasia (AML/TMDS) achieved CR with the continuous drip infusion of low-dose etoposide and low-dose cytosine arabinoside combined with mitoxantrone (MEtA)].
    Tsukaguchi M, Furukawa Y, Shibano M, Kitani T.
    Gan To Kagaku Ryoho; 2004 Jul; 31(7):1119-23. PubMed ID: 15272598
    [Abstract] [Full Text] [Related]

  • 15. De novo acute myelogenous leukemia with trilineage myelodysplasia associated with t(8;21)(q22;q22).
    Fujisawa S, Togawa J, Tanaka M, Koharazawa H, Aoba M, Fujita H, Murata T, Kanamori H, Matsuzaki M, Mohri H, Ishigatsubo Y.
    Intern Med; 1999 Jul; 38(7):607-11. PubMed ID: 10435370
    [Abstract] [Full Text] [Related]

  • 16. Fludarabine, cytarabine, G-CSF and idarubicin (FLAG-IDA) for the treatment of poor-risk myelodysplastic syndromes and acute myeloid leukaemia.
    Parker JE, Pagliuca A, Mijovic A, Cullis JO, Czepulkowski B, Rassam SM, Samaratunga IR, Grace R, Gover PA, Mufti GJ.
    Br J Haematol; 1997 Dec; 99(4):939-44. PubMed ID: 9432047
    [Abstract] [Full Text] [Related]

  • 17. Long-term outcome of intensive chemotherapy for adults with de novo acute myeloid leukaemia (AML): the nationwide AML-92 study by the Finnish Leukaemia Group.
    Koistinen P, Räty R, Itälä M, Jantunen E, Koivunen E, Nousiainen T, Pelliniemi TT, Remes K, Ruutu T, Savolainen ER, Siitonen T, Silvennoinen R, Volin L, Elonen E, Finnish Leukaemia Group.
    Eur J Haematol; 2007 Jun; 78(6):477-86. PubMed ID: 17391337
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Clonal remissions in acute myeloid leukaemia are commonly associated with features of trilineage myelodysplasia during remission.
    Jowitt SN, Liu Yin JA, Saunders MJ, Lucas GS.
    Br J Haematol; 1993 Dec; 85(4):698-705. PubMed ID: 7918032
    [Abstract] [Full Text] [Related]

  • 20. Prognostic value of dysmyelopoietic features in de novo acute myeloid leukaemia: a report on 132 patients.
    Estienne MH, Fenaux P, Preudhomme C, Lai JL, Zandecki M, Lepelley P, Cosson A.
    Clin Lab Haematol; 1990 Dec; 12(1):57-65. PubMed ID: 2344717
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.